サウスカロライナにおけるクローン病の臨床試験
サウスカロライナ内の拠点で、クローン病に関する12件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/05更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates, PA, Greenville
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06233461A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Johns Hopkins University Gastroenterology and Hepatology-Site Number: 8400116, Columbia
- Biocentric Health Research Center-Site Number: 8400089, Columbia
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Palmetto Gastroenterology Clinical Research, Summerville
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/22更新 · NCT06226883A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Medical University of South Carolina (MUSC), Charleston
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/01/15更新 · NCT06257706ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。